Who owns GSK? Superinvestor holders

11 superinvestors of the 157 tracked here hold GSK in their latest 13F filing, with $5.5B between them. Dodge & Cox team gives it the most weight: 1.12% of the reported portfolio.

Brandon Haley and Sarah Ketterer sold out of it in their latest quarter.

Hold it now
11
of 157 tracked
Combined value
$5.5B
Bought / sold
5 / 8
last quarter

Key facts

Superinvestors holding it
11 of 157
Biggest holder
Dodge & Cox team, $2.1B
Largest weight
Dodge & Cox team, 1.12%of their portfolio
Combined value
$5.5B
Bought last quarter
5
Sold last quarter
8

From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.

Superinvestors holding GSK, latest filings
#InvestorShare of their portfolioValueSharesLast quarterShares movedQuarter
1Dodge & Cox teamDodge & Cox1.12%$2.1B43.18M▼ Reduced 10%−5.01MQ3 2026
2Thomas KahnKahn Brothers0.91%$5.5M113.55K▼ Reduced 28%−44.89KQ3 2026
3Primecap teamPrimecap Management0.75%$1.2B25.19M▲ Added 0.04%+10.07KQ3 2026
4Charles Brandes (founder)Brandes Investment Partners0.50%$72.2M1.5M▲ Added 1.0%+15.28KQ3 2026
5Ken FisherFisher Investments0.49%$1.7B35.35M▼ Reduced 1.0%−371.52KQ3 2026
6Jeremy Grantham (co-founder)GMO (Grantham, Mayo, Van Otterloo)0.41%$188.7M3.92M▲ Added 8.9%+318.55KQ3 2026
7Tweedy, Browne teamTweedy, Browne Company0.30%$3.7M77.44K▼ Reduced 5.0%−4.08KQ3 2026
8Steve CohenPoint72 Asset Management0.21%$139.1M2.65MNew+2.65MQ2 2026
9Howard GleicherAristotle Capital Management0.12%$53.9M1.12M▼ Reduced 24%−344.66KQ3 2026
10Murray StahlHorizon Kinetics0.01%$1.1M23K▼ Reduced 4.4%−1.05KQ3 2026
11Richard PzenaPzena Investment Management0.00%$1.4M28.96K▲ Added 18%+4.46KQ3 2026

Sold out last quarter

Quarter by quarter

Superinvestor ownership of GSK by quarter
QuarterFilings inHoldersCombined sharesCombined valueBoughtSold
Q3 20269210110.51M$5.3B47
Q2 202615712118.6M$6.2B58
Q1 202615713131.41M$7.3B410
Q4 202515712143.46M$7B56
Q3 202515712152.48M$6.6B66
Q2 202515713152.68M$5.9B84
Q1 202515612148.46M$5.8B75
Q4 202415610123.96M$4.2B73

A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.

Each holder's shares

Shares of GSK held by each superinvestor, by quarter
InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Dodge & Cox team43.18M48.2M58.66M68.52M78.4M78.76M78.65M68.44M
Ken Fisher35.35M35.72M34.52M33.2M32.23M31.34M30.03M18.84M
Primecap team25.19M25.18M25.2M25.13M25.77M27.73M25.71M25.26M
Jeremy Grantham (co-founder)3.92M3.6M3.52M3.49M2.57M2.6M2.14M4.15M
Charles Brandes (founder)1.5M1.48M1.45M1.72M1.87M1.77M1.68M1.36M
Howard Gleicher1.12M1.46M1.53M1.56M1.61M1.63M1.68M1.6M
Thomas Kahn113.55K158.44K160.98K178.7K260.84K659.87K822.23K884.71K
Tweedy, Browne team77.44K81.53K81.79K82.24K82.24K86.87K90.55K93.82K
Richard Pzena28.96K24.51K18.82K13.44K8.72K7.51K——
Murray Stahl23K24.05K24.42K——37.39K38.67K—
Steve Cohen·2.65M——————
Sarah Ketterer—7.16K11.11K33.9K1.18M1.11M1.11M1.08M
Brandon Haley·—5.52M8.12M7.1M5.61M5.31M—
Ray Dalio (founder)·—698.67K1.42M1.4M1.34M1.2M2.25M

A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.

Questions and answers

Which superinvestors own GSK?

In their latest 13F filings: Dodge & Cox team (1.12% of the portfolio, $2.1B), Thomas Kahn (0.91% of the portfolio, $5.5M), Primecap team (0.75% of the portfolio, $1.2B), Charles Brandes (founder) (0.50% of the portfolio, $72.2M), Ken Fisher (0.49% of the portfolio, $1.7B), Jeremy Grantham (co-founder) (0.41% of the portfolio, $188.7M), Tweedy, Browne team (0.30% of the portfolio, $3.7M), Steve Cohen (0.21% of the portfolio, $139.1M), and 3 more.

Who bought GSK last quarter?

Primecap team (added 0.0%), Charles Brandes (founder) (added 1.0%), Jeremy Grantham (co-founder) (added 8.9%), Steve Cohen (new position), Richard Pzena (added 18%). “Last quarter” is each investor's latest reported quarter.

Who sold GSK last quarter?

Reduced: Dodge & Cox team (10% fewer shares), Thomas Kahn (28% fewer shares), Ken Fisher (1.0% fewer shares), Tweedy, Browne team (5.0% fewer shares), Howard Gleicher (24% fewer shares), Murray Stahl (4.4% fewer shares). Sold out entirely: Brandon Haley (was $304.6M), Sarah Ketterer (was $375.5K).

How current is this?

It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.

Learn

Cite this page

Funkfolio, “Who owns GSK? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/GSK/superinvestors

Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.

Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to GSK by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.